- Home
- MCW vs SUPN Comparison
MCW vs SUPN Comparison
Compare MCW & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCW
- SUPN
- Stock Information
- Founded
- MCW 1996
- SUPN 2005
- Country
- MCW United States
- SUPN United States
- Employees
- MCW N/A
- SUPN N/A
- Industry
- MCW
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- MCW
- SUPN Health Care
- Exchange
- MCW Nasdaq
- SUPN Nasdaq
- Market Cap
- MCW 2.2B
- SUPN 1.9B
- IPO Year
- MCW 2021
- SUPN 2012
- Fundamental
- Price
- MCW $6.48
- SUPN $32.07
- Analyst Decision
- MCW Hold
- SUPN Hold
- Analyst Count
- MCW 6
- SUPN 2
- Target Price
- MCW $8.46
- SUPN $36.00
- AVG Volume (30 Days)
- MCW 1.6M
- SUPN 672.8K
- Earning Date
- MCW 07-30-2025
- SUPN 08-05-2025
- Dividend Yield
- MCW N/A
- SUPN N/A
- EPS Growth
- MCW 4.42
- SUPN N/A
- EPS
- MCW 0.24
- SUPN 1.11
- Revenue
- MCW $1,017,200,000.00
- SUPN $667,997,000.00
- Revenue This Year
- MCW $7.57
- SUPN N/A
- Revenue Next Year
- MCW $7.57
- SUPN $12.02
- P/E Ratio
- MCW $25.99
- SUPN $28.93
- Revenue Growth
- MCW 8.18
- SUPN 11.82
- 52 Week Low
- MCW $5.84
- SUPN $25.55
- 52 Week High
- MCW $8.60
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- MCW 49.02
- SUPN 49.97
- Support Level
- MCW $5.92
- SUPN $30.93
- Resistance Level
- MCW $6.31
- SUPN $32.78
- Average True Range (ATR)
- MCW 0.21
- SUPN 1.01
- MACD
- MCW 0.04
- SUPN -0.06
- Stochastic Oscillator
- MCW 90.32
- SUPN 50.20
About MCW Mister Car Wash Inc.
Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. Express Exterior Locations offers express exterior cleaning services and Interior Cleaning Locations offers both express exterior and interior cleaning services. The company recognizes revenue from activities related to providing car wash services at its car wash locations that are geographically diversified throughout the United States and have similar economic characteristics and nature of services.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.